Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• Phototherapy could reduce need for transfusions in HDFN

  Intensive phototherapy using super light-emitting diode bed technology may be more effective than blood transfusions in treating HDFN.

• Study shows end tidal carbon monoxide tracking could predict HDFN outcomes

  A recent study shows end-tidal carbon monoxide concentration measured during the first 48 hours after birth could predict HDFN outcomes.

• HDFN and blood transfusions after trauma: ethical considerations

  The ethical implications of administering RhD-positive blood products to women of childbearing potential with life-threatening hemorrhage.

• Study shows most frequent cause of HDFN is ABO incompatibility

  ABO antigen incompatibility appears to be the most frequent cause of HDFN, leading to exchange transfusions during the neonatal period, a study showed.

• Immunological mechanism may explain HDFN therapy success

  An immunological mechanism called thrombocytosis could explain the effectiveness of Rh immunoglobulin (RHIG) preventive therapy for HDFN.

• Doppler ultrasound may improve HDFN outcomes, study shows

  The study showed fetal venous parameters measured through Doppler ultrasound appear to be closely correlated with clinical outcomes in HDFN.

• Study: Kell antigen monitoring could improve HDFN outcomes

  Monitoring Kell antigen levels in pregnancies complicated with HDFN could help physicians determine the need for intrauterine transfusions.

• Study: Third trimester screening for HDFN may be unnecessary

  Third-trimester screening for antibodies capable of producing HDFN could be deemed unnecessary due to the low seroconversion rate.

• IV immunoglobulin shows promise in pregnancies at risk of HDFN

  IVIG could delay the need for intrauterine transfusions and decrease hemolysis in pregnancies at risk of developing HDFN, according to a recent study.

• Study shows correlation between GMA and CTT tests in HDFN

  The study underscores the correlation between GMA and CTT titers, offering insights into blood compatibility testing for HDFN patients.